20 Results for "

P19 EC

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "P19 EC" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-17447A
CAS No.: 1986-47-6
Synonyms: SKF 385 hydrochloride
Tranylcypromine hydrochloride (SKF 385 hydrochloride) is an irreversible inhibitor of lysine-specific demethylase 1 (LSD1/BHC110) and monoamine oxidase (MAO). Tranylcypromine hydrochloride inhibits LSD1, MAO A and MAO B with IC50s of 20.7, 2.3 and 0.95 μM, respectively. Tranylcypromine hydrochloride can be used for the research of depression .
loading...
    loading...
Cat. No.: HY-P99248
CAS No.: 1612838-76-2
Synonyms: Risankizumab rzaa; BI 655066; ABBV-066

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd <10 pM) and inhibiting IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis .
loading...
    loading...
Cat. No.: HY-P9931
CAS No.: 1350289-85-8
Synonyms: CNTO 1959

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits production of cytokines lying downstream of the IL-23 signaling pathway and can be used for psoriatic arthritis research .
loading...
    loading...
Cat. No.: HY-P99737
CAS No.: 1884201-71-1
Synonyms: LY­3074828

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin 23 (IL-23). Mirikizumab binds to human and monkey IL-23 with high affinity, with Kd values of 21 pM and 55 pM, respectively. By inhibiting the binding of IL-23 to IL-23R, Mirikizumab modulates the immune response and holds potential for research in ulcerative colitis and Crohn's disease .
loading...
    loading...
Cat. No.: HY-P990217

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Anti-Mouse IL-23 p19 Antibody (G23-8) is a rat-derived anti-mouse IL-23 p19 IgG1 monoclonal antibody. Anti-Mouse IL-23 p19 Antibody (G23-8) alleviates inflammation by restoring CLDN8 expression. Anti-Mouse IL-23 p19 Antibody (G23-8) can be used for research on inflammation conditions such as colitis and asthma .
loading...
    loading...
Cat. No.: HY-P99256
CAS No.: 1326244-10-3
Synonyms: SCH 900222; MK 3222; Anti-Human IL23 RECombinant Antibody

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology Cancer

Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis .
loading...
    loading...
Cat. No.: HY-P99485
CAS No.: 1610353-18-8
Synonyms: AMG 139; MEDI2070

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease .
loading...
    loading...
Cat. No.: HY-P990057
CAS No.: 2622900-74-5
Synonyms: IBI-112

Target:  

Interleukin Related

Research Areas:  

Cancer

Picankibart is a human-derived IgG1κ antibody targeting IL23A. Picankibart specifically binds to the IL23 p19 subunit and exerts an anti-inflammatory effect by blocking the IL23-mediated signaling pathway.
loading...
    loading...
Cat. No.: HY-P1494
CAS No.: 57468-17-4
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease

Substance P (1-9) is nonapeptide, which decreases the inactivation of substance P by the guinea-pig ileum and urinary bladder.
loading...
    loading...
Cat. No.: HY-108440
CAS No.: 326886-05-9
Purity:  99.88%
Target:  

Myosin

Research Areas:  

Cardiovascular Disease

Shz-1, a small cardiogenic molecule, induces various cardiac-specific genes including sarcomeric tropomyosin in P19CL6 cells. Shz-1 induces Nkx2.5 expression in mouse. Shz-1 activates the axolotl TPM4 promoter-driven ectopic expression in C2C12 cells .
loading...
    loading...
Cat. No.: HY-P991277
Synonyms: HS-20137

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

QX-004N (HS-20137) is a monoclonal antibody inhibitor targeting the p19 subunit of interleukin-23 (IL-23). QX-004N is promising for research of immune system diseases and diseases of digestive system .
loading...
    loading...
Cat. No.: HY-P991274

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

BMS-986010 is a monoclonal antibody inhibitor targeting the p19 subunit of interleukin-23 (IL-23). BMS-986010 reduces IL-23-induced STAT3 phosphorylation and inhibits Th17 cell differentiation and the release of proinflammatory cytokines (such as IL-17 and TNF-α). BMS-986010 is promising for research of autoimmune diseases such as psoriasis and Crohn's disease .
loading...
    loading...
Cat. No.: HY-147934
CAS No.: 2432825-93-7
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC8-IN-3 (compound P19) is a potent HDAC8 inhibitor with IC50 value of 9.3 μM and produces thermal stabilization. HDAC8-IN-3 has cytotoxicity and induces apoptosis in leukemic cell lines .
loading...
    loading...
Cat. No.: HY-P11198
Research Areas:  

Cancer

AC-P19M is an anticancer peptide. AC-P19M induces apoptosis by disrupting the cell membrane of cancer cells. AC-P19M reverses epithelial-mesenchymal transition (EMT). AC-P19M shows anti-angiogenic activity through the inhibition of VEGF-VEGFR2/ERK/Akt signaling. AC-P19M can be used for lung cancer research .
loading...
    loading...
Cat. No.: HY-P991408
DLX-105 is a human monoclonal antibody (mAb) targeting TNFSF2/TNFa. DLX-105 reduces skin epidermal thickness and the expression of K16 and Ki67. DLX-105 down-regulates the mRNA levels of IL-17, TNF-α, IL-23p19, IL-12p40, and IFN-γ. DLX-105 can be used in psoriasis research .
loading...
    loading...
Cat. No.: HY-180977
CAS No.: 2512843-74-0
Target:  

PROTACs Bcr-Abl

Research Areas:  

Cancer

P19P is a BCR-ABL PROTAC degrader based on Ponatinib (HY-12047), with a DC50 value of approximately 20 nM for the wild-type BCR-ABL protein. P19P can effectively degrade various drug-resistant mutants such as T315I, E255K, H396R, and V468F, and exhibits potent anti-proliferative activity in BaF3-BCR-ABL (T315I) cells. P19P maintains strong inhibitory activity against ABL (T315I), with a IC50 of 13.1 nM. P19P does not inhibit the formation of vascular lumens in HUVEC. P19P can be used for research on chronic myeloid leukemia and acute lymphoblastic leukemia .
loading...
    loading...
Cat. No.: HY-180981
CAS No.: 2635386-55-7
Target:  

PROTACs Bcr-Abl

Research Areas:  

Cancer

P19As is a BCR-ABL PROTAC degrader based on Asciminib (HY-104010), with a DC50 value of approximately 200 nM for the wild-type BCR-ABL protein. P19As can degrade the T315I mutant and exhibits potent anti-proliferative activity in BaF3-BCR-ABL (T315I) cells. P19As can be used for the study of chronic myeloid leukemia and acute lymphoblastic leukemia .
loading...
    loading...
Cat. No.: HY-180978
Target:  

PROTAC Linkers

Research Areas:  

Cancer

H2N-PEG3-C2-Trizole-C3-COOH is a is a PEG-based PROTAC linker that can be used for the synthesis of PROTACs, such as P19As (HY-180981) and P19P (HY-180977) .
loading...
    loading...
Cat. No.: HY-180982
CAS No.: 3106065-83-9
Research Areas:  

Cancer

Asciminib-NH2 is a BCR-ABL ligand and can be used for the synthesis of PROTACs, such as P19As (HY-180981) .
loading...
    loading...
Cat. No.: HY-108440R
CAS No.: 326886-05-9
Research Areas:  

Cardiovascular Disease

Shz-1 (Standard) is the analytical standard of Shz-1 (HY-108440). This product is intended for research and analytical applications. Shz-1, a small cardiogenic molecule, induces various cardiac-specific genes including sarcomeric tropomyosin in P19CL6 cells. Shz-1 induces Nkx2.5 expression in mouse. Shz-1 activates the axolotl TPM4 promoter-driven ectopic expression in C2C12 cells .
loading...
    loading...
  • 1